Arvinas (ARVN) Amortization of Deferred Charges (2021 - 2026)
Arvinas (ARVN) reported Amortization of Deferred Charges of $3.2 million for Q2 2026, up 700.0% from $400,000 a year earlier and up 966.7% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arvinas' Amortization of Deferred Charges came in at $4.1 million, down 37.9% year-over-year; for FY2025, it was $4.3 million, down 6.5% from FY2024.
- Amortization of Deferred Charges has a four-year compound annual growth rate of 81.1% (FY2021 to FY2025).
- By year, Amortization of Deferred Charges came in at $4.6 million in FY2024 (+253.8%), $1.3 million in FY2023 (-27.8%), $1.8 million in FY2022 (+350.0%) and $400,000 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Amortization of Deferred Charges since Q1 2025.
- Year over year, Amortization of Deferred Charges gained in three of the last seven quarters, with growth averaging 198.0%.
- The high point for year-over-year Amortization of Deferred Charges in five years was Q1 2025 (growth of 725.0%); the low point was Q1 2026 (a decline of 90.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $300,000 (Q1 2026), $200,000 (Q4 2025) and $400,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Arvinas | 483.87 Mn | -2.17 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20 Mn |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | -700,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 600,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 100,000.00 |
API Access
Arvinas Amortization of Deferred Charges API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-of-deferred-charges", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();